62 / 490
60
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
SATURDAY 30 APRIL 2016
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
09:35 > Future selection practice for proton therapy: selection of patients
based on treatment planning comparison and NTCP-modelling
Speaker: H. Langendijk (The Netherlands)
SP-0011
Symposium
MITIGATING NORMAL TISSUE TOXICITY
08:45 - 10:00 | LONDRA
The session is a well balanced session consisting of two biologically-oriented and experimental talks
(by S. van der Veen and L. Meziani) and one clinically oriented (by S. Delanian). The first talk will show
the benefit triggered by molecular modulation using ACE inhibitors on cardiopulmonary function and
cardiac damage. The second will review the clinical benefit of the combination Pentoxifyllin, Vitamin
E and Clodronate with possible mechanistic insights. The third will show the contribution of innate
immune system to late radiation-induced pulmonary damages with a specific focus on macrophages
leading to innovative therapeutic intervention.
Chair: M-C Vozenin (Switzerland)
Co-Chair: L. Pirtoli (Italy)
08:45 > The use of ACE inhibitors to attenuate thoracic irradiation-induced
cardiopulmonary toxicity.
Speaker: S. Van der Veen (The Netherlands)
SP-0012
09:10 > Radiation-induced musculosqueletic late damages: possible clinical
cure or simple mitigation?
Speaker: S. Delanian (France)
SP-0013
09:35 > Radiation-induced lung fibrosis is associated with M2 interstitial and
hybrid alveolar macrophages
Speaker: L. Meziani (France)
SP-0014
Symposium
REGIONAL NODAL IRRADIATION FOR BREAST CANCER
08:45 - 10:00 | AUDITORIUM
The first speaker in this session will review conflicting data around surgical and radiotherapeutic man-
agement of the axilla in breast cancer patients and how these impact on current clinical practice.
The second speaker will review recently published data on irradiation of the internal mammary chain
(IMC) with a view to determining whether every node-positive patient should have the IMC irradiated.
The final talk will cover technical approaches to treating locoregional lymph nodes and will review the
evidence base for dose constraints, the dosimetric consequences of different technical approaches
including protons, and the resource impact on our departments.
Chair: A. Kirby (UK)
Co-Chair: R. Orecchia (Italy)